Candriam SCA’s Brookfield BN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.46M Buy
36,097
+1,670
+5% +$74K 0.01% 565
2025
Q4
$1.58M Buy
34,427
+14,448
+72% +$659K 0.01% 530
2025
Q3
$914K Buy
19,979
+627
+3% +$27.8K ﹤0.01% 585
2025
Q2
$797K Sell
19,352
-4,305
-18% -$160K ﹤0.01% 611
2025
Q1
$825K Buy
23,657
+1,743
+8% +$65.9K 0.01% 606
2024
Q4
$839K Hold
21,914
﹤0.01% 603
2024
Q3
$777K Sell
21,914
-705
-3% -$22.3K ﹤0.01% 603
2024
Q2
$627K Hold
22,619
﹤0.01% 611
2024
Q1
$632K Sell
22,619
-3,006
-12% -$81.1K ﹤0.01% 644
2023
Q4
$689K Buy
25,625
+176
+0.7% +$4K ﹤0.01% 633
2023
Q3
$533K Sell
25,449
-19,298
-43% -$435K ﹤0.01% 619
2023
Q2
$1.01M Sell
44,747
-3,330
-7% -$70.6K 0.01% 601
2023
Q1
$960K Buy
48,077
+7,622
+19% +$172K 0.01% 702
2022
Q4
$848K Sell
40,455
-10,831
-21% -$243K 0.01% 735
2022
Q3
$1.14M Hold
51,286
0.01% 685
2022
Q2
$1.23M Sell
51,286
-1,002
-2% -$26.8K 0.01% 599
2022
Q1
$1.59M Sell
52,288
-4,863
-9% -$145K 0.01% 591
2021
Q4
$1.86M Sell
57,151
-12,512
-18% -$396K 0.01% 561
2021
Q3
$2.01M Buy
69,663
+1,060
+2% +$30.9K 0.01% 574
2021
Q2
$1.89M Sell
68,603
-7,727
-10% -$198K 0.01% 589
2021
Q1
$1.62M Hold
76,330
0.01% 560
2020
Q4
$1.69M Sell
76,330
-164
-0.2% -$3.28K 0.01% 572
2020
Q3
$1.35M Sell
76,494
-2,967
-4% -$53K 0.01% 560
2020
Q2
$1.37M Buy
79,461
+1,506
+2% +$26.5K 0.01% 551
2020
Q1
$1.57M Hold
77,955
0.02% 577
2019
Q4
$1.61M Sell
77,955
-67,625
-46% -$1.35M 0.02% 594
2019
Q3
$2.76M Sell
145,580
-56,660
-28% -$1.03M 0.04% 437
2019
Q2
$3.44M Sell
202,240
-71,472
-26% -$1.21M 0.04% 411
2019
Q1
$4.55M Sell
273,712
-125,694
-31% -$1.96M 0.06% 347
2018
Q4
$5.46M Sell
399,406
-252,061
-39% -$3.76M 0.08% 266
2018
Q3
$10.3M Buy
651,467
+167,152
+35% +$2.54M 0.14% 186
2018
Q2
$7.01M Buy
484,315
+314,680
+186% +$4.49M 0.11% 229
2018
Q1
$2.36M Sell
169,635
-3,425
-2% -$49.6K 0.04% 443
2017
Q4
$2.7M Buy
173,060
+3,938
+2% +$59.5K 0.05% 394
2017
Q3
$2.49M Sell
169,122
-14,440
-8% -$203K 0.04% 413
2017
Q2
$2.57M Sell
183,562
-48,569
-21% -$654K 0.05% 415
2017
Q1
$3.01M Buy
232,131
+48,524
+26% +$615K 0.06% 364
2016
Q4
$2.16M Buy
183,607
+1,340
+0.7% +$16.3K 0.05% 355
2016
Q3
$2.28M Sell
182,267
-865,184
-83% -$10.6M 0.05% 335
2016
Q2
$12.3M Buy
1,047,451
+896,114
+592% +$10.7M 0.32% 81
2016
Q1
$1.85M Sell
151,337
-194,991
-56% -$2.1M 0.05% 335
2015
Q4
$3.82M Sell
346,328
-427,108
-55% -$5.01M 0.1% 214
2015
Q3
$8.51M Buy
773,436
+168,463
+28% +$1.96M 0.21% 143
2015
Q2
$7.43M Buy
604,973
+300,822
+99% +$3.83M 0.15% 179
2015
Q1
$3.81M Sell
304,151
-862,303
-74% -$10.7M 0.08% 299
2014
Q4
$13.7M Buy
+1,166,454
New +$13.1M 0.29% 110

Other funds holding BN

Candriam SCA's BN Position: Q1 2026 in Review

Candriam SCA increased its Brookfield (BN) stake by 4.9% in Q1 2026, buying an estimated $74K and bringing the position to 36,097 shares worth $1.46M. The position accounts for 0.01% of the portfolio, ranked #565.

Candriam SCA first reported a position in BN in Q4 2014 and has held it in 46 quarters since. The position peaked at $13.7M in Q4 2014. 914 funds tracked by Wall St. Rank hold BN as of Q1 2026.

  • Candriam SCA held 36,097 shares of Brookfield worth $1.46M as of Q1 2026.
  • Candriam SCA bought 1,670 Brookfield shares in Q1 2026, an estimated $74K.
  • Brookfield made up 0.01% of Candriam SCA's portfolio in Q1 2026, its #565 holding.
  • Candriam SCA first reported a position in Brookfield in Q4 2014 and has held it in 46 quarters since.
  • Candriam SCA's Brookfield position peaked at $13.7M in Q4 2014.
  • 914 funds tracked by Wall St. Rank held Brookfield as of Q1 2026.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.